Lung tissue sustained and controlled release material loaded with BMP4 and GANT61 and preparation method of lung tissue sustained and controlled release material

By preparing lung tissue sustained-release materials loaded with BMP4 and GANT61, and utilizing anionic ring-opening polymerization and nanoparticle technology, we achieved effective induction of myofibroblast transdifferentiation in vivo, overcoming the shortcomings of existing technologies in pulmonary fibrosis treatment and providing better anti-inflammatory and antioxidant effects.

CN120960460APending Publication Date: 2025-11-18THE FIRST PEOPLES HOSPITAL OF FOSHAN
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511162404.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-08-19
Publication Date
2025-11-18

Smart Images

  • Figure CN120960460A_ABST
    Figure CN120960460A_ABST
Patent Text Reader

Abstract

The invention provides a lung tissue sustained and controlled release material loaded with BMP4 and GANT61 and a preparation method of the lung tissue sustained and controlled release material, and relates to the technical field of disease treatment and delivery materials. The invention relates to a preparation method of a lung tissue sustained and controlled release material loaded with BMP4 and GANT61. The preparation method comprises the following steps: synthesizing HPG by adopting an anionic ring-opening polymerization method; the preparation method comprises the following steps: mixing HPG with PLA, and reacting to prepare a copolymer PLA-HPG; the copolymer PLA-HPG and GANT61 are blended and subjected to a reaction, and nano particles loaded with GANT61 are prepared; and the GANT61-loaded nano particles and BMP4 are subjected to a mixed reaction, such that the BMP4 and GANT61-loaded lung tissue sustained and controlled release material is prepared. The invention constructs a lung tissue sustained and controlled release material loaded with BMP4 and GANT61, and verifies that the lung tissue sustained and controlled release material can realize an anti-pulmonary fibrosis treatment strategy by inducing alpha-SMA + myofibroblast transdifferentiation, resisting inflammation, resisting oxidation and other multiple targets.
Need to check novelty before this filing date? Find Prior Art